54 related articles for article (PubMed ID: 7986748)
1. Regulation of vimentin gene transcription in human breast cancer cell lines.
Sommers CL; Skerker JM; Chrysogelos SA; Bosseler M; Gelmann EP
Cell Growth Differ; 1994 Aug; 5(8):839-46. PubMed ID: 7986748
[TBL] [Abstract][Full Text] [Related]
2. Activation and inhibition of the AP-1 complex in human breast cancer cells.
Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
[TBL] [Abstract][Full Text] [Related]
3. Hormonal regulation of the c-fms proto-oncogene in breast cancer cells is mediated by a composite glucocorticoid response element.
Flick MB; Sapi E; Kacinski BM
J Cell Biochem; 2002; 85(1):10-23. PubMed ID: 11891846
[TBL] [Abstract][Full Text] [Related]
4. PEA3, AP-1, and a unique repetitive sequence all are involved in transcriptional regulation of the breast cancer-associated gene, mammaglobin.
Hesselbrock DR; Kurpios N; Hassell JA; Watson MA; Fleming TP
Breast Cancer Res Treat; 2005 Feb; 89(3):289-96. PubMed ID: 15754128
[TBL] [Abstract][Full Text] [Related]
5. A negative regulatory factor is missing in a human metastatic breast cancer cell line.
Stover DM; Carey I; Garzon RJ; Zehner ZE
Cancer Res; 1994 Jun; 54(12):3092-5. PubMed ID: 8205522
[TBL] [Abstract][Full Text] [Related]
6. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells.
Briggs J; Chamboredon S; Castellazzi M; Kerry JA; Bos TJ
Oncogene; 2002 Oct; 21(46):7077-91. PubMed ID: 12370830
[TBL] [Abstract][Full Text] [Related]
8. Cyclic AMP regulation of mouse proline-rich protein gene expression: isoproterenol induction of AP-1 transcription factors in parotid glands.
Zhou J; Wright PS; Wong E; Jessen K; Morand JN; Carlson DM
Arch Biochem Biophys; 1997 Feb; 338(1):97-103. PubMed ID: 9015393
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional activation of the human claudin-18 gene promoter through two AP-1 motifs in PMA-stimulated MKN45 gastric cancer cells.
Yano K; Imaeda T; Niimi T
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G336-43. PubMed ID: 18032479
[TBL] [Abstract][Full Text] [Related]
10. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
11. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
12. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
Kutz SM; Providence KM; Higgins PJ
Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3 modulates MUC2 mucin expression in human colon cancer cells at the level of transcription via AP-1 activation.
Song S; Byrd JC; Mazurek N; Liu K; Koo JS; Bresalier RS
Gastroenterology; 2005 Nov; 129(5):1581-91. PubMed ID: 16285957
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional analysis of the control region of the human DNA topoisomerase II alpha gene in drug-resistant cells.
Takano H; Ise T; Nomoto M; Kato K; Murakami T; Ohmori H; Imamura T; Nagatani G; Okamoto T; Ohta R; Furukawa M; Shibao K; Izumi H; Kuwano M; Kohno K
Anticancer Drug Des; 1999 Apr; 14(2):87-92. PubMed ID: 10405635
[TBL] [Abstract][Full Text] [Related]
15. Eosinophilic inflammation: mechanisms regulating IL-5 transcription in human T lymphocytes.
Wang J; Young IG
Allergy; 2007 Oct; 62(10):1131-8. PubMed ID: 17845581
[TBL] [Abstract][Full Text] [Related]
16. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
[TBL] [Abstract][Full Text] [Related]
17. Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.
Anisowicz A; Sotiropoulou G; Sager R
Mol Med; 1999 Aug; 5(8):526-41. PubMed ID: 10501656
[TBL] [Abstract][Full Text] [Related]
18. Negative regulation of a special, double AP-1 consensus element in the vimentin promoter: interference by the retinoic acid receptor.
Van de Klundert FA; Jansen HJ; Bloemendal H
J Cell Physiol; 1995 Jul; 164(1):85-92. PubMed ID: 7790400
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional activation and DNase I hypersensitive sites are associated with selective expression of the gastrin-releasing peptide gene.
Markowitz S; Krystal G; Lebacq-Verheyden AM; Way J; Sausville EA; Battey J
J Clin Invest; 1988 Sep; 82(3):808-15. PubMed ID: 2843572
[TBL] [Abstract][Full Text] [Related]
20. Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogene-transformed mammary epithelial cells.
Sommers CL; Walker-Jones D; Heckford SE; Worland P; Valverius E; Clark R; McCormick F; Stampfer M; Abularach S; Gelmann EP
Cancer Res; 1989 Aug; 49(15):4258-63. PubMed ID: 2472876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]